Daiichi Sankyo Announces Launch of Immune-mediated Inflammatory Diseases Consortium for Drug Development Read more
Pfizer Announces FDA Approves XELJANZ (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis Read more
Five Prime Therapeutics Announces Collaboration with Roche to Develop Companion Diagnostics for Targeted Immuno-Oncology Investigational Drug Candidates Read more
Exploring the Future Through Ocular Gene Editing and Strategic Drug Delivery at Ophthalmic Drugs 2018 Read more
Machines are now intelligent, robots are ‘stealing jobs’, and your next meeting might be led by a bot. How will AI disrupt your life? Read more